Published in Eur J Clin Pharmacol on May 17, 2003
Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep (2009) 2.89
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med (2007) 1.17
A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. Br J Clin Pharmacol (2006) 0.97
Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci (2015) 0.97
Use of non-benzodiazepine sedative hypnotics and risk of falls in older men. J Gerontol Geriatr Res (2014) 0.85
Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep (2012) 0.85
Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. Br J Clin Pharmacol (2008) 0.84
Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference. BMC Geriatr (2008) 0.81
Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. BMC Geriatr (2014) 0.79
Factors associated with falls in the elderly: a community study. Age Ageing (1981) 3.82
Memory-scanning: mental processes revealed by reaction-time experiments. Am Sci (1969) 3.58
A longitudinal study of falls in an elderly population: I. Incidence and morbidity. Age Ageing (1977) 1.86
Factor analysis of a sleep evaluation questionnaire. Psychol Med (1978) 1.67
The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review. Psychopharmacology (Berl) (1980) 1.67
Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs (2000) 1.52
Standardization in platform stabilometry being a part of posturography. Agressologie (1983) 1.36
Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs (1990) 1.29
Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs (1986) 1.05
The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol (1992) 1.02
Oxidative metabolism of zolpidem by human liver cytochrome P450S. Drug Metab Dispos (1995) 0.96
Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacol Biochem Behav (1988) 0.91
Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol (1993) 0.88
Drug treatment as a cause of falls in old age. A review of the offending agents. Drugs Aging (1992) 0.88
Selective effects of zolpidem on human memory functions. J Psychopharmacol (1999) 0.87
Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav (1998) 0.86
Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors. Mol Pharmacol (1993) 0.85
Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry (1995) 0.83
Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fundam Clin Pharmacol (1987) 0.81
Effects of daytime administration of zolpidem versus triazolam on memory. Eur J Clin Pharmacol (1995) 0.80
Hypnotics and behavior. Am J Med (1990) 0.80
Acute effects of amitriptyline on human performance and interactions with diazepam. Eur J Clin Pharmacol (1988) 0.80
Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging (1994) 0.78
[Residual effects on the equilibrium of 3 hypnotics (loprazolam, flunitrazepam, triazolam) assessed by spectrum analysis of postural oscillations]. Therapie (1987) 0.77
Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. Pharmacol Toxicol (1992) 0.76
Effects of hypnotics on memory. Pharmacology (1983) 0.76
Residual effects of lormetazepam on mood and performance in healthy elderly volunteers. Eur J Clin Pharmacol (1991) 0.76
Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. Neuropsychobiology (1994) 0.75
Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. A study of untreated unsomniacs. Pharmacopsychiatry (1998) 0.75
Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection. J Chromatogr (1990) 0.75
Lormetazepam, memory and information processing: a review. Psychopharmacol Ser (1988) 0.75
Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging (2005) 1.49
Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Hum Psychopharmacol (2004) 1.06
Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res (2006) 1.06
Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids. Drug Saf (2004) 1.02
Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring. Antimicrob Agents Chemother (2011) 1.00
Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application. Clin Chem Lab Med (2010) 0.98
Effect of the intensity of training on catecholamine responses to supramaximal exercise in endurance-trained men. Eur J Appl Physiol (2003) 0.89
Safety and pharmacokinetics of single and multiple ascending doses of avibactam alone and in combination with ceftazidime in healthy male volunteers: results of two randomized, placebo-controlled studies. Clin Drug Investig (2015) 0.86
Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects. Hum Psychopharmacol (2000) 0.86
Plasma glucose, insulin and catecholamine responses to a Wingate test in physically active women and men. Eur J Appl Physiol (2003) 0.84
Acute and chronic anxiogenic-like response to fluoxetine in rats in the elevated plus-maze: modulation by stressful handling. Behav Brain Res (2011) 0.84
The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients. J Clin Virol (2007) 0.84
Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatr Dis Treat (2007) 0.83
Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers. Fundam Clin Pharmacol (2002) 0.83
Alzheimer's disease: the pharmacological pathway. Fundam Clin Pharmacol (2003) 0.82
Pharmacology of Alzheimer's disease: appraisal and prospects. Dement Geriatr Cogn Disord (2005) 0.81
Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography. Ther Drug Monit (2002) 0.81
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women. Br J Clin Pharmacol (2007) 0.79
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma. Clin Chem Lab Med (2010) 0.79
Pharmacogenomics. Med Sci Monit (2002) 0.78
[Pharmacologic treatment of insomnia in children and adolescent psychiatric patients]. Therapie (2010) 0.78
Drug therapy of frontotemporal dementia. Hum Psychopharmacol (2003) 0.78
Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. Hum Psychopharmacol (2003) 0.78
Sex effect on catecholamine responses to sprint exercise in adolescents and adults. Pediatr Exerc Sci (2007) 0.78
Disease-modifying drugs and Parkinson's disease. Prog Neurobiol (2007) 0.78
[Therapeutic drug monitoring of gabapentin]. Therapie (2010) 0.78
Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*. Curr Med Res Opin (2008) 0.78
[Pharmacology of Alzheimer's disease: where do we go from here?]. Therapie (2005) 0.77
Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances. Behav Brain Res (2009) 0.77
Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances? Fundam Clin Pharmacol (2004) 0.77
Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma. Ther Drug Monit (2005) 0.77
Treatment of the mild cognitive impairment (MCI). Hum Psychopharmacol (2007) 0.77
Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative 'Pre-Review' Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis. Dev World Bioeth (2014) 0.76
[Influence of menstrual cycle phase on catecholamine response to sprint exercise in the woman]. Appl Physiol Nutr Metab (2006) 0.76
[Therapeutic drug monitoring of levetiracetam]. Therapie (2010) 0.76
[Aripiprazole use in children and adolescent psychiatric patients]. Therapie (2011) 0.76
[Risperidone use in child and adolescent psychiatric patients]. Therapie (2009) 0.76
Subthalamic nucleus modulates social and anxogenic-like behaviors. Behav Brain Res (2013) 0.76
The anti-dementia drugs: myth, hype or reality? Curr Opin Neurol (2003) 0.75
[Therapeutic drug monitoring of stiripentol]. Therapie (2012) 0.75
Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. Br J Clin Pharmacol (2005) 0.75
Mild cognitive impairment: a treatment at last? Lancet Neurol (2004) 0.75
[Therapeutic drug monitoring of zonisamide]. Therapie (2010) 0.75
The anti-dementia drugs: myth, hype or reality? Clin Neuropharmacol (2006) 0.75
[Level of evidence for therapeutic drug monitoring of low dose methotrexate in inflammatory diseases]. Therapie (2011) 0.75
[Therapeutic drug monitoring]. Therapie (2010) 0.75
[Therapeutic drug monitoring of oxcarbazepine]. Therapie (2010) 0.75
[Pharmacological treatment in severe dementia]. Psychol Neuropsychiatr Vieil (2005) 0.75
[Biology of motivation]. Psychol Neuropsychiatr Vieil (2004) 0.75
[Level of evidence for therapeutic drug monitoring of ceftriaxone]. Therapie (2012) 0.75
[Therapeutic drug monitoring of quinine]. Therapie (2011) 0.75
[Therapeutic drug monitoring of felbamate]. Therapie (2010) 0.75
[Therapeutic drug monitoring of clonazepam]. Therapie (2010) 0.75
Major discrepancy between digoxin immunoassay results in a context of acute overdose: a case report. Clin Chim Acta (2004) 0.75